Blood and Marrow Transplantation Long Term Management. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Blood and Marrow Transplantation Long Term Management - Группа авторов страница 40

Blood and Marrow Transplantation Long Term Management - Группа авторов

Скачать книгу

+ + + Muscle and connective tissue Evaluation of muscle weakness 2 2 2 Physical activity counseling 1 1 1 Skeletal Bone density testing (Adult women, all allogeneic recipients, all patients at high risk for bone loss) 1 + Nervous system Neurologic clinical evaluation + 1 1 Evaluation for cognitive development 1 1 Further workup if clinically indicated (e.g., MRI, EMG, neuropsychiatry testing) + + + Endocrine Thyroid function testing 1 1 Growth velocity in children 1 1 Gonadal function assessment (prepubertal men and women) 1 1 1 Gonadal function assessment (postpubertal women) 1 + Gonadal function assessment (postpubertal men) + + Referral to an endocrinologist when replacement therapy needed + + Mucocutaneous Skin self‐examination and sun exposure counseling 1 1 1 Gynecologic examination in women + 1 1 Gonadal examination in men + +/2 +/2 Referral to dermatologist if indicated + + + Second cancers Second cancer vigilance counseling 1 1 Screening for second cancers 1 1 Psychosocial Psychosocial / QoL clinical assessment* 1 1 1 Sexual function assessment 1 1 1 Spousal/caregiver/family functioning assessment 1 1 1 Fertility Consider referral to appropriate specialist for counseling + + + Counsel regarding birth control posttransplantation + + + General Health lifestyle recommendations (Table 5.2) 1 1 1

      1, recommended for all HSCT recipients; 2, recommended for patients with ongoing GVHD or immunosuppression; +, recommended for abnormal testing in a previous time period or for new signs/symptoms.

      * including inquiry about school/work attendance, need for social support/disability pension, financial toxicity.

      1 1. Institute of Medicine, National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition: An American Society of Clinical Oncology and Institute of Medicine Symposium. Washington, DC: The National Academies Press, 2006.

      2 2. Denzen EM, Preussler JM, Murphy EA, et al. Tailoring a survivorship care plan: patient and provider preferences for recipients of hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019; 25(3):562–569.

      3 3. Majhail NS, Murphy E, Laud P, et al. Randomized controlled trial of individualized treatment summary and survivorship care plans for

Скачать книгу